IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$497.76 USD
-8.62 (-1.70%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $497.62 -0.14 (-0.03%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth C Momentum D VGM
Idexx Laboratories (IDXX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$570.60 | $650.00 | $500.00 | 12.68% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Idexx Laboratories comes to $570.60. The forecasts range from a low of $500.00 to a high of $650.00. The average price target represents an increase of 12.68% from the last closing price of $506.38.
Analyst Price Targets (10)
Broker Rating
Idexx Laboratories currently has an average brokerage recommendation (ABR) of 1.77 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.71 a month ago based on 12 recommendations.
Of the 11 recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 54.55% and 9.09% of all recommendations. A month ago, Strong Buy made up 58.33%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 7 | 7 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.77 | 1.77 | 1.71 | 1.71 | 1.77 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Exane BNP Paribas | Navann Ty | Strong Buy | Strong Buy |
8/13/2024 | Piper Sandler | David M Westenberg | Hold | Hold |
8/1/2024 | Not Identified | Not Identified | Hold | Hold |
7/25/2024 | BTIG | Mark Massaro | Not Available | Strong Buy |
7/17/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
5/2/2024 | Atlantic Equities | Steven K Chesney | Hold | Hold |
5/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/17/2024 | Goldman Sachs | Nathan Rich | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.77 |
ABR (Last week) | 1.77 |
# of Recs in ABR | 11 |
Average Target Price | $570.60 |
LT Growth Rate | 11.30% |
Industry | Medical - Instruments |
Industry Rank by ABR | 72 of 253 |
Current Quarter EPS Est: | 2.69 |
IDXX FAQs
IDEXX Laboratories, Inc. (IDXX) currently has an average brokerage recommendation (ABR) of 1.77 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms.
The average price target for IDEXX Laboratories, Inc. (IDXX) is $570.60. The current on short-term price targets is based on 6 reports.
The forecasts for IDEXX Laboratories, Inc. (IDXX) range from a low of $500 to a high of $650. The average price target represents a increase of $12.68 from the last closing price of $506.38.
The current UPSIDE for IDEXX Laboratories, Inc. (IDXX) is 12.68%
Based on short-term price targets offered by 10 analysts, the average price target for Idexx Laboratories comes to $570.60. The forecasts range from a low of $500.00 to a high of $650.00. The average price target represents an increase of 12.68% from the last closing price of $506.38.